Meal timing matters: study tests edaravone absorption after different foods
NCT ID NCT05342597
First seen Jun 27, 2026 · Last updated Jul 16, 2026 · Updated 2 times
Summary
This study looked at how eating different types of meals affects the way the body absorbs oral edaravone, a medication used for ALS. Sixteen healthy Japanese adults took the drug under five different dietary conditions, including fasting. The goal was to understand how food changes drug levels in the blood and urine, which helps guide dosing instructions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY ADULT SUBJECTS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Investigational site
Tokyo, Japan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a new pill help regulate blood sugar? early trial puts PSTC100 to the test
- First human trial launches for experimental PSTB100 drug
- Syringe showdown: does a prefilled device deliver drug as well as a vial?
- Healthy volunteers help unlock the Body's handling of a new drug
- New edaravone tablet tested in healthy volunteers
- Healthy volunteers test new Drug's body processing